Constance Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $4.75M
Latest Deal Amount
  • Investors
  • 3

Constance Therapeutics General Information

Description

Producer of medicinal cannabis products intended to offer alternative approaches to treat critically ill patients. The company's products uses raw materials with controlled genetics that have been sustainably grown and are also based on modern herbalist principles, enabling physicians to have expanded treatment options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Medical Supplies
Primary Office
  • 981 Howard Street
  • San Francisco, CA 94103
  • United States
+1 (415) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Constance Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 05-Mar-2018 $4.75M 00.000 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 11-Jul-2016 000 000 0000 Completed Generating Revenue
To view Constance Therapeutics’s complete valuation and funding history, request access »

Constance Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
To view Constance Therapeutics’s complete cap table history, request access »

Constance Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Constance Finley Founder, Board Member and Chief Executive Officer
To view Constance Therapeutics’s complete executive team members history, request access »

Constance Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Constance Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ARTIS Ventures Venture Capital Minority 000 0000 000000 0
Big Rock Venture Capital Minority 000 0000 000000 0
Slow Ventures Venture Capital Minority 000 0000 000000 0
To view Constance Therapeutics’s complete investors history, request access »